agent), L. bozemanii, L. dumoffii, L. longbeachae, and other species together account for the remaining 10%. The collective clinical syndromes resulting from infection by members of the Legionellaceae family is referred to as legionellosis.
Strains of L. pneumophila differ in virulence. For example, multiple strains will colonize the water distribution system, but only a few strains will cause disease in patients exposed to that water. Of the 15 serogroups of L. pneumophila, serogroups 1, 4, and 6 are responsible for the majority of human infections. The point pertinent to this review is that L. pneumophila causes more severe disease than other bacterial pathogens associated with communityacquired pneumonia. For example, patients with community-acquired Legionnaires' disease are more likely to be admitted to intensive care units than patients with other pneumonias. The mortality for Legionnaires' disease is notably higher than the other "atypical" pneumonias in which L. pneumophila is included (with Chlamydia pneumonia and Mycoplasma pneumoniae) and is similar to that of bacteremic pneumococcal pneumonia.
EPIDEMIOLOGY
The incidence of Legionnaires' disease depends on several factors, including the extent of contamination of the water reservoir by the organism, susceptibility of the population exposed to that water, and the degree or intensity of the exposure of the patient to the water reservoir. Furthermore, the experience of the testing laboratory and availability of specialized tests are critical to discovery of the infection and establishment of the diagnosis.
Cigarette smoking, advanced age, chronic lung disease are well-established risk factors in immunocompetent hosts. Immunosuppression including receipt of corticosteroids is a major risk factor. Solid organ transplant recipients are at highest risk for Legionnaires' disease. 1, 2 Legionnaires' disease occurs infrequently in patients with HIV disease, but when it occurs, a complicated course including lung abscesses, bacteremia, and extrapulmonary involvement is common. Finally, legionellosis in immunosuppressed children is increasingly being reported; most cases have been nosocomial, usually acquired in neonatal or pediatric intensive care units (ICUs). 3, 4 The most common source for infection is the potable water distribution system. In addition to hospitals, cases have been linked to potable water within hotels, office buildings, work places, apartment buildings, and even private residences. 5, 6 It is not well known that aerosol-generating devices are actually uncommon sources of Legionnaires' disease. Cooling towers are now known to be overestimated as the source for community-acquired Legionnaires' disease. 7
COMMUNITY-ACQUIRED PNEUMONIA
Despite differences in geographic location, patient population, and laboratory methods applied, numerous studies of community-acquired pneumonia over the past 18 years have produced surprisingly consistent results as to the likely etiological agents in the immunocompetent individual. We evaluated 19 prospective studies that reported 6845 cases of community-acquired pneumonia requiring hospitalization ( Table 1) . As expected, Streptococcus pneumoniae was the most common bacterial pathogen identified worldwide (Table 1) . Legionella pneumophila was ranked among the top five most common causes of community-acquired pneumonia in 12 of 19 studies (Table 1) , but if the pneumonia warranted intensive care unit admission, it was among the top five most common causes in 8 of 9 studies (Table 2) .
NOSOCOMIAL PNEUMONIA
Nosocomial Legionnaires' disease occurs in the context of a contaminated water supply. Comparative studies of hospital water supplies hospital water supplies have shown that in hospital in which Legionella was not present in the water, the incidence of nosocomial Legionnaires' disease was zero. [8] [9] [10] [11] [12] [13] [14] On the other hand, for hospitals with a contaminated potable water supply, the incidence of Legionnaires' disease has approached 40% of all nosocomial pneumonias. 8 Nosocomial Legionnaires' disease is vastly underdiagnosed primarily because cultures on multiple selective media are generally not available inhouse. In a survey of 192 hospitals participating in the National Nosocomial Infections Surveillance System, 40% of hospitals had no in-house laboratory testing for Legionella. 2 Only 19% of hospitals performed laboratory testing for Legionellosis in those hospitals with transplant and cancer programs-patients in these programs are at high risk for Legionnaires' disease! Incredibly, even for those hospitals experiencing cases of nosocomial Legionnaires' disease, only 21% had routine Legionella laboratory testing policies for respiratory specimens.
SEVERE PNEUMONIA
At the current time, no consensus definition of "severe" community-acquired pneumonia has achieved standardization. Ewig and Torres 15 suggested that a combination of hypotension, multilobar involvement of chest radiograph, arterial hypoxemia, and mechanical ventilator be used to define severe pneumonia. Because few of the published studies explicitly listed all of the above criteria, we applied the commonly used subjective criteria of admission to the ICU to define "severe pneumonia." 16 For this review, we focused on nine studies that reported 890 cases of communityacquired pneumonia in which admission to the ICU was required (Table 2) . [17] [18] [19] [20] [21] [22] [23] [24] [25] The most conspicuous finding was that S. pneumoniae and L. pneumophila were the most frequently identified etiologic agents. Mortality from these cases of severe pneumonia in these nine studies ranged from 8 to 29%. Mortality from severe Legionnaires' disease in this series ranged from 0 to 25%. Aerobic Gram-negative bacilli ranked third overall, although few of these cases could be considered as "definitive" (i.e., confirmed by bacteremia or isolation of Gram-negative bacilli from pleural fluid or lung tissue). Moreover, the precise contribution of patients from nursing homes could not be ascertained in most studies (these patients are more likely to have Gram-negative pneumonias). In these nine studies, the frequency of mechanical ventilation among patients with severe pneumonia ranged from 9 to 91%, and with a mean mortality rate among mechanically ventilated patients of 35% with a range of 31 to 42%. Mortality among mechanically ventilated patients with severe Legionnaires' disease ranged from 0 to 25%.
CLINICAL MANIFESTATIONS
The predominant clinical manifestation of Legionnaires' disease is pneumonia. Classically, patients with atypical pneumonias usually have a relatively nonproductive cough and grossly purulent sputum is uncommon. The Gram's stain of sputum shows numerous polymorphonuclear leukocytes, with very few or no organisms seen. As mentioned previously, the clinical manifestations of Legionnaires' disease are usually more severe than those of the other atypical pneumonias caused by viruses, C. pneumoniae, and M. pneumoniae. It should be noted that in the early studies of Legionnaires' disease, investigators reported that there was a characteristic syndrome reflecting a pneumonia of unusual clinical severity. Notable clinical manifestations included gastrointestinal symptoms especially diarrhea, relative bradycardia (pulse-temperature defect), and nonspecific neurological symptoms (headache and mental status changes). Laboratory abnormalities included renal dysfunction, hepatic dysfunction, hyponatremia, hypophophatemia, and hematuria. 26, 27 Development of respiratory failure and chest radiograph progression were more common in Legionnaires' disease than in pneumonias of other etiology. 25 In 1982, we published a comparative pneumonia study in which clinical manifestations and laboratory parameters for Legionnaires' disease were compared to those of other bacterial etiologies (mostly aspiration pneumonia, Streptococcus pneumoniae, Haemophilus influenzae, aerobic Gram-negative bacilli, Staphylococcus aureus). 28 We found that clinical manifestations of Legionnaires' disease was similar to those of other bacterial etiologies. We did confirm that hyponatremia occurred significantly more often in patients with Legionnaire' disease; other investigators have also noted this significant association. [29] [30] [31] Since then, more than 10 comparative studies of pneumonia have confirmed that the clinical presentation of Legionnaires' disease is nonspecific. We believe that the earlier studies were biased toward more patients with severe clinical manifestations for two reasons: (1) laboratory diagnostic methods for Legionella were rarely ordered by physicians in their first encounter in patients with Legionnaires' disease leading to delay of correct diagnosis, (2) effective anti-Legionella antibiotic therapy was rarely given to patients with Legionnaires' disease because beta-lactam antibiotics, especially cephalosporins, were the empiric antibiotics of choice for pneumonia up until the early 1990s.
On the other hand, Cunha 32 has advocated for a syndromic approach and has even devised an elaborate point system for the diagnosis of Legionnaires' disease. Points were assigned for lethargy, diarrhea, abdominal pain, relative bradycardia for temperature Ն102°F. Points were deducted for productive cough, sore throat, ear pain, and hoarseness. The higher the number of points, the more likely the diagnosis of Legionnaires' disease. Interestingly, in a preliminary study, De Carolis et al 33 have found this point system to be relatively sensitive in the diagnosis of Legionnaires' disease, but not specific. In a prospective comparative study of pneumococcal pneumonia versus Legionnaires' disease, Falco et al 25 found that gastrointestinal symptoms (abdominal pain, nausea, vomiting, diarrhea) and neurological symptoms (headache, confusion, delirium) were significantly more frequent in Legionnaires' disease. In contrast, upper respiratory tract symptoms, productive cough with purulent sputum, and pleuritic chest pain were significantly more frequent in pneumococcal pneumonia. Similarly, hepatic enzymes and serum creatinine were more likely to be elevated in Legionnaires' disease. In this study, 30 patients had Legionnaires' disease, and 67% were culture-proven. Sopena et al 30 found diarrhea and headache to be significantly more frequent in 48 patients with Legionnaires' disease than in pneumonias of other etiology. Productive cough and chest pain were seen more commonly in pneumonias of other etiology. Serum creatinine phosphokinase was also significantly higher in Legionnaires' disease. Investigators from the Community-Based Pneumonia Incidence Study Group also suggested a syndromic approach based on a multivariate analysis of patients hospitalized for community-acquired pneumonia; 53 patients had Legionnaires' disease. They found that fever Ն 102°F, headache, elevated serum lactate dehydrogenase (LDH) > 700 U/L, and hyponatremia were significantly more likely to occur in Legionnaires' disease. 34 Finally, Blatter et al 35 suggested that temperature Ն 39°C and presence of cough without purulent sputum were more likely in a study in which 18 patients had Legionnaires' disease.
We remain skeptical of the utility of the syndromic approach in a setting in which physician index of suspicion is high for Legionnaires' disease and laboratory testing for Legionella is available. In such a scenario, cases of Legionnaires' disease will be diagnosed earlier, such that the severe clinical manifestations associated with a syndromic approach will be muted. On the other hand, in patients who present to the physician late in the course of disease, or in patients in whom the diagnosis of Legionnaires' disease is mistakenly overlooked by the physician, application of the syndromic approach may suggest the correct diagnosis. Therefore, we recommend that for patients with pneumonia of sufficient severity to be admitted to the ICU, application of the syndromic approach warrants evaluation in a validation cohort. If a trend favoring the utility of the syndromic approach can be documented, such an approach may be useful to clinicians in increasing the index of suspicion for Legionnaires' disease.
In any case, the following clinical observations should heighten clinical suspicion of Legionnaires' disease: (1) fever exceeding 39°C; (2) presence of diarrhea, (3) Gram's stain of sputum with presence of neutrophils, but few, if any, organisms are visible; (4) hyponatremia (serum sodium Յ 130 meg/L), (5) failure of a therapeutic response to ␤-lactam (penicillin or cephalosporin) or aminoglycoside antimicrobial agent; and (6) occurrence in a setting of known contamination of the potable water supply with Legionella.
RADIOLOGICAL MANIFESTATIONS
Abnormalities in the chest radiograph are generally nonspecific. However, progression of infiltrates despite appropriate antibiotic therapy, presence of pleural effusions, evidence of pleural-based infiltrates that clinically mimic pulmonary embolism, and circumscribed peripheral densities are suggestive of pneumonia caused by Legionella. 36 The initial radiographic finding is a unilateral alveolar infiltrate that may progress to lobar consolidation. Radiographic abnormalities are seen by the third day of the illness in virtually all the patients. Patchy and diffuse infiltrates, or segmental or lobar infiltrates may be seen at presentation. Multilobar involvement may become evident despite antibiotic therapy. 37. Circumscribed peripheral densities and nodules are typically seen in immunosuppressed patients. These can rapidly progress with a tendency to cavitate. Cavitation and abscess formation are uncommon features of Legionnaires' disease in the immunocompetent patient, but can be quite impressive in patients receiving corticosteroids. 38 Cavitary disease may develop up to 14 days after initial presentation despite appropriate antibiotic therapy. Pleural effusions are evident in one third of patients with Legionnaires' disease and may herald the pulmonary infiltrate. Empyema and pericardial effusion have been described. The degree of radiographic abnormalities does not necessarily correlate with the clinical severity or outcome. Radiographic improvement in patients with Legionnaires' disease often lags behind clinical response, and several weeks to months may pass before the infiltrates resolve completely. 37 
LABORATORY TESTING
Specialized laboratory testing is required to make the diagnosis of Legionnaires' disease since the clinical and radiographic presentation is nonspecific (Table 3) . Five specialized tests have been used for diagnosis of Legionnaires' disease: serology, culture, direct fluorescent antibody (DFA) stain, culture on selective media, and polymerase chain reaction (PCR). Three of the tests are applied to respiratory secretions (direct fluorescent antibody [DFA], culture, PCR), and two of the tests use blood (serology) or urine specimens (urinary antigen). Three of the tests are considered "rapid" tests, that is, results are available within hours of test performance; they are the urinary antigen, DFA, and PCR. We recommend that the urinary antigen for Legionella and culture on selective media be available in-house in every hospital laboratory.
GRAM STAIN
Gram's staining of pleural fluid or lung tissue may allow visualization of small, pleomorphic, faint Gram-negative bacilli that is characteristic of Legionella. The organism is not easily seen in sputum. Legionella micdadei are occasionally seen on modified acid-fast stains.
CULTURE
Recovery of the organism from respiratory secretions on buffered charcoal yeast extract (BCYE) culture media is the definitive method of diagnosis. Standard bacteriological media do not support the growth of Legionella. Three media need to be used for maximal sensitivity: (1) BCYE media, (2) BCYE supplemented with polymyxin, anisomycin, vancomycin and dyes, (3) BCYE supplemented with polymyxin, anisomycin, and cefamandole. 39 Acid wash pretreatment of sputum is also necessary to reduce overgrowth of competing microflora. Specimens obtained by bronchoscopy are not necessarily superior to expectorated sputum. Macroscopically visible colonies appear after 3 to 5 days of growth. Nonpurulent sputum with few polymorphonuclear leukocytes and numerous squamous epithelial cells are traditionally considered to be inadequate specimens for cultures; however, many such specimens have yielded L. pneumophila by culture. 25, 40 
DFA STAIN
DFA stain is a rapid test that allows direct visualization of Legionella in clinical specimens. Positive results with this staining method depends on a large burden of organisms and is more likely to be positive if there is extensive pulmonary disease on chest radiograph at presentation. 37 False-positive results are usually due to improper laboratory technique or contamination.
ANTIBODY DETECTION
Serological detection of antibodies directed against Legionella is made by either indirect fluorescent antibody or enzyme-linked immunosorbent assays (ELISA). Diagnosis requires that acute and convalescent sera demonstrate a fourfold rise in antibody titer to 1:128. Both IgM and IgG antibody titers should be performed. A single titer of 1:256 in a patient with pneumonia has been considered as presumptive evidence of Legionnaires' disease, although Plouffe et al 41 found this cutoff to be insensitive. Titers may be elevated in 25 to 40% of patients during the first week of illness. Convalescent sera at three different time points are needed for maximal sensitivity: at the time of presentation, 4 to 6 weeks later, and 3 to 6 months later. Serology is used primarily for epidemiological studies or to verify a suspected diagnosis. It cannot be used for decisionmaking on antibiotic therapy because it may take weeks to obtain a result.
URINARY ANTIGEN
A new, rapid immunochromatographic assay (NOW, Binax, S. Portland, ME) is an improvement over previous radioimmunoassay and ELISA tests with respect to ease of performance. Urine is often easier to obtain than sputum and results are not affected by antibiotics. The test is available only for L. pneumophila serogroup 1, although this serogroup accounts for at least 90% of Legionella infections.
POLYMERASE CHAIN REACTIONS
This rapid method has been used to detect Legionella in urine samples, bronchoalveolar lavage fluid, and serum. Current assays have not proven more sensitive than culture, such that technical improvements are required before PCR can be widely applied.
TREATMENT
The newer macrolides, especially azithromycin, have displaced erythromycin as the antibiotic of choice. Azithromycin, roxithromycin, clarithromycin have superior lung tissue penetration and more potent intracellular and in vitro activity than erythromycin.
The quinolones (levofloxacin, ciprofloxacin, moxifloxacin, gemifloxacin, trovafloxacin) also demonstrate superior in vitro activity and improved pharmacokinetics such that once-daily dosing is feasible. In vitro, all the quinolones are more potent than azithromycin, the current macrolide of choice. Moreover, clinical trials have confirmed the efficacy of levofloxacin and ciprofloxacin for cases of culture-confirmed Legionnaires' disease. Therapy with the fluroquinolones, especially levofloxacin or ciprofloxacin, is recommended for organ transplant recipients with Legionnaires' disease. The macrolides (but not azithromycin) interact with tacrolimus and cyclosporin-immunosuppressive drugs used following organ transplantation. There is no data on the utility of combination therapy, although we have used combination therapy in seriously ill patients with confirmed Legionnaires' disease; this might include immunosuppressed patients with multilobar disease or patients with respiratory failure. The most common combination therapy that we have used is levofloxacin plus azithromycin. Rifampin has also been used in combination therapies. Rifampin interacts with tacrolimus and cyclosporin, which may result in marked reductions in the levels of the immunosuppressive drugs so that its use in transplant patients should be limited.
The dosages of the various drugs are shown in Table 4 . Duration of therapy of 10 to 14 days is usually sufficient; however, a 21-day course of therapy has been recommended for immunosuppressed patients or for those with extensive pulmonary disease as evidenced by radiographic abnormalities.
Delay in administration of appropriate antibiotic therapy for Legionnaires' disease significantly increases mortality. 25, 42 Because of the high incidence of Legionnaires' disease in cases of severe pneumonia (Table 2) , empiric therapy for Legionellosis should be included in every patient admitted to the ICU with undiagnosed pneumonia. We recommend that immunocompetent patients with severe pneumonia of uncertain etiology be given one of two empiric regimens at outset: (1) ceftriaxone plus azithromycin or (2) levofloxacin, moxifloxacin, or gemifloxacin as monotherapy. Both of the above regimens would provide coverage for Legionella, penicillin-resistant pneumococci, and aerobic Gram-negative bacilli-problem pathogens in patients admitted to the ICU. Adjunctive therapy with extracorporeal membrane oxygenation for severe Legionnaires' disease has been reported to be effective in patients with acute respiratory failure. 43 
PREVENTION
We recommend routine environmental cultures of the hospital water supply regardless of whether nosocomial Legionnaires' disease has been diagnosed. 44 If Legionella is isolated, culture on selective media should be made available in-house rather than being sent to reference laboratories. The Centers for Disease Control and Prevention have opposed this approach claiming that the cost efficacy of routine environmental cultures in the absence of known nosocomial Legionnaires' disease is uncertain. However, health departments in several states in the United States and national communicable disease centers in Europe are now formulating guidelines mandating routine environmental cultures for Legionella. Disinfection modalities can be applied to the water distribution system if necessary. Super-heat-and-flush can be applied immediately to terminate an outbreak. 45 Copper-silver ionization systems can be installed for long-term disinfection. Hyperchlorination is no longer recommended. 
